24 Paul Tudor Jones II Natera Trades
Paul Tudor Jones II's position in Natera is currently worth $34.9M. That's 0.17% of their equity portfolio (105th largest holding). The first Natera trade was made in Q1 2016. Since then Paul Tudor Jones II bought shares eighteen more times and sold shares on fifteen occasions. The stake costed the investor $31M, netting the investor a gain of 13% so far.
News about Natera Inc and Paul Tudor Jones II
Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced an analysis from the IMvigor011 study ...
Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a collaboration with the Fédération Fr...
Natera Announces Completion of Enrollment to the Randomized, Phase III ALTAIR Trial of Signatera™ in Colorectal Cancer | NTRA Stock News
Natera, Inc., a global leader in cell-free DNA testing, today announced the completion of enrollment to the randomized,